Int. J. Mol. Sci. 2012, 13(12), 16053-16064; doi:10.3390/ijms131216053
Article

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer

Jiarui Li 1,† email, Zhang Ping 1,† email and Hui Ning 2,* email
1 Department of Gynecology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China 2 Department of Gynecology and Obstetrics, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, China † These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 28 August 2012; in revised form: 15 October 2012 / Accepted: 25 October 2012 / Published: 28 November 2012
(This article belongs to the Section Molecular Pathology)
PDF Full-text Download PDF Full-Text [1102 KB, uploaded 28 November 2012 11:54 CET]
Abstract: MicroRNAs are noncoding RNA molecules of 18–25 nucleotides that regulate gene expression at the post-transcriptional levels. Recent data revealed that miR-218 played key roles in tumor metastasis. Here, we described the regulation and function of miR-218 in cervical cancer. Overexpression of miR-218 reduced the proliferation of the human cervical cancer cell line HeLa and induced cell apoptosis through the AKT-mTOR signaling pathway. In addition, it forced expression of miR-218 suppressed tumor growth in the orthotopic mouse model of HeLa cells. Furthermore, miR-218 increased chemosensitivity to cisplatin (CDDP) in vitro. Our results indicated that targeting miR-218 may provide a strategy for blocking the development of cervical cancer.
Keywords: miR-218; cervical cancer; HeLa; cisplatin

Supplementary Files

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Li, J.; Ping, Z.; Ning, H. MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer. Int. J. Mol. Sci. 2012, 13, 16053-16064.

AMA Style

Li J, Ping Z, Ning H. MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer. International Journal of Molecular Sciences. 2012; 13(12):16053-16064.

Chicago/Turabian Style

Li, Jiarui; Ping, Zhang; Ning, Hui. 2012. "MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer." Int. J. Mol. Sci. 13, no. 12: 16053-16064.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert